🇮🇳IN
Sign In
SM

SMSPHARMA

NSE

SMS Pharmaceuticals Ltd

₹414.60

-14.05(-3.28%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

SMSPHARMA financial summary

For Mar 2026, SMS Pharmaceuticals Ltd reported revenue of ₹887 crore, which grew 13.3% from the previous year. Net profit was ₹88 crore, which grew 29.4% year on year, on an operating margin of 19%. Earnings per share came in at ₹9.35. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹887 crore
Net profit₹88 crore
Operating margin19%
EPS₹9.35

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer